Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma

Summary

The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.

Timeline

Start

2026-01-05

Primary completion

2031-08-30

Completion

2031-12-31

Drugs

Indications